Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease

被引:45
作者
Aerts, Johannes M. F. G. [1 ]
Kuo, Chi-Lin [1 ]
Lelieveld, Lindsey T. [1 ]
Boer, Daphne E. C. [1 ]
van der Lienden, Martijn J. C. [1 ]
Overkleeft, Herman S. [1 ]
Artola, Marta [1 ]
机构
[1] Leiden Univ, Leiden Inst Chem, Einsteinweg 55, NL-2300 RA Leiden, Netherlands
基金
欧洲研究理事会;
关键词
Glycosphingolipids; Lysosome; Gaucher disease; Glucocerebrosidase; Glucosylsphingosine; IN-SITU VISUALIZATION; GANGLIOSIDE GM3; GLUCOCEREBROSIDASE ACTIVITY; PLASMA CHITOTRIOSIDASE; MARKED ELEVATION; FABRY DISEASE; ENZYME; GENE; GLUCOSYLCERAMIDE; QUANTIFICATION;
D O I
10.1016/j.cbpa.2019.10.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glycosphingolipids are important building blocks of the outer leaflet of the cell membrane. They are continuously recycled, involving fragmentation inside lysosomes by glycosidases. Inherited defects in degradation cause lysosomal glycosphingolipid storage disorders. The relatively common glyco-sphingolipidosis Gaucher disease is highlighted here to discuss new insights in the molecular basis and pathophysiology of glyco-sphingolipidoses reached by fundamental research increasingly using chemical biology tools. We discuss improvements in the detection of glycosphingolipid metabolites by mass spectrometry and review new developments in laboratory diagnosis and disease monitoring as well as therapeutic interventions.
引用
收藏
页码:204 / 215
页数:12
相关论文
共 50 条
  • [31] Facial features of lysosomal storage disorders
    D'Souza, Andrea
    Ryan, Emory
    Sidransky, Ellen
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (06) : 467 - 474
  • [32] Impairment of Homeostasis in Lysosomal Storage Disorders
    Segatori, Laura
    IUBMB LIFE, 2014, 66 (07) : 472 - 477
  • [33] Levels of Lyso GL-1 in Gaucher and Lyso GL-3 in Fabry patients from India: Diagnostic aids for these lysosomal storage disorders
    Verma, Jyotsna
    Roy, Papai
    Thomas, Divya C.
    Puri, Ratna Dua
    Verma, I. C.
    CLINICA CHIMICA ACTA, 2021, 521 : 177 - 190
  • [34] Treating lysosomal storage disorders: What have we learnt?
    Lachmann, Robin H.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (01) : 125 - 132
  • [35] A perspective on research, diagnosis, and management of lysosomal storage disorders in Colombia
    Alejandra Puentes-Tellez, Maria
    Andrea Lerma-Barbosa, Paula
    Guillermo Garzon-Jaramillo, Rafael
    Suarez, Diego A.
    Espejo-Mojica, Angela J.
    Guevara, Johana M.
    Yaneth Echeverri, Olga
    Solano-Galarza, Daniela
    Uribe-Ardila, Alfredo
    Almeciga-Diaz, Carlos J.
    HELIYON, 2020, 6 (03)
  • [36] The Lysosome and Nonmotor Symptoms: Linking Parkinson's Disease and Lysosomal Storage Disorders
    Blumenreich, Shani
    Jenkins, Bethan J.
    Barav, Or B.
    Milenkovic, Ivan
    Futerman, Anthony H.
    MOVEMENT DISORDERS, 2020, 35 (12) : 2150 - 2155
  • [37] From Lysosomal Storage Disorders to Parkinson's Disease-Challenges and Opportunities
    Maechtel, Rebecca
    Boros, Fanni Annamaria
    Dobert, Jan Philipp
    Arnold, Philipp
    Zunke, Friederike
    JOURNAL OF MOLECULAR BIOLOGY, 2023, 435 (12)
  • [38] Lysosomal storage disease overview
    Sun, Angela
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (24)
  • [39] Current and Emerging Therapies for Lysosomal Storage Disorders
    Lastoria, Diego Agustin Abelleyra
    Keynes, Sophie
    Hughes, Derralynn
    DRUGS, 2025, 85 (02) : 171 - 192
  • [40] Immunomodulatory Gene Therapy in Lysosomal Storage Disorders
    Koeberl, Dwight D.
    Kishnani, Priya S.
    CURRENT GENE THERAPY, 2009, 9 (06) : 503 - 510